Pharma News

Pharma Courses 
PAGE Admission

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • IOL Chemicals and Pharmaceuticals  has received US FDA approval for marketing APIs in US after successful inspection of its ibuprofen manufacturing facility situated at Barnala in Punjab. The said facility at Barnala has also been approved by ANVISA Brazil, WHO and MOH Japan. These approvals will help to build and sustaining the growth by its API business in coming years.

  • 25 July 2015
    Hospira launches generic bivalirudin for injection in US market

    The US Food and Drug Administration (FDA) has granted marketing approval for Hospira, Inc.'s bivalirudin for injection, a generic version of The Medicines Company's Angiomax.

  • Scientists have discovered thousands of toxins hidden deep within the venom of a sea cone snail in Queensland, which may help develop new drugs to treat pain, cancer and other diseases. Researchers used biochemical and bioinformatics tools to develop a new method to analyse the structure of the venom toxins, allowing them to delve deeper than ever before.

  • (Business Wire India); Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that it has delivered a strong consolidated financial performance for Q1 FY16.

  • GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.

  • Trivitron Healthcare has added two new products in the newborn screening kit for India. The two new tests are Neonatal IRT and Neonatal Toxoplasma gondii IgM that detect disorders which may harm the newborn in later stages of life. Neonatal IRT can detect disorders affecting the lungs, pancreas, intestine and liver. Whereas, Neonatal Toxoplasma gondii IgM can detect neurological and visual disabilities.

  • Researchers develop a tiny wireless device that, once implanted in the brain, can be activated by remote control to deliver targeted drugs. Size of device is of the width of a human hair. It may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain areas. The researchers believe that similar, more flexible devices could have applications in other areas of the body too, including peripheral organs. The study is published in the Cell.

    [adsense:336x280:8701650588]

  • Novartis, the world's second largest pharmaceutical company, has announced that its antimalarial medicine Coartem 80/480mg received World Health Organisation (WHO) prequalification, making it the first and only high strength (80/480mg) artemisinin-based combination therapy (ACT) antimalarial treatment available for public sector procurement. This new dosage strength has the potential to improve malaria management.

  • Bosch, a leading global supplier of technology and services, has got the Zinnov Awards for its Eyecare device that was adjudged as an innovation with a potential to solve large scale global problems.

  • (NewsVoir); Randstad, one of the country’s leading HR service providers, today launched an exclusive ‘Talent Trends Report – HR Game Changers’ at the 12th edition of the NASSCOM HR Summit, held in Chennai. The report offers an overview of the top 15 workplace trends that will shape talent management in 2015 and beyond.

Subscribe to Pharma News